Effects of preoperative beta-hydroxy-beta-methylbutyrate, arginine, and glutamine supplementation on cardiac surgery: A randomized controlled trial
Clinical Nutrition · 2025-02 · 45 · 91-100
DOI: 10.1016/j.clnu.2024.12.030 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition, 2025-02. Verfasst von Masato Ogawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan; Department of Rehabilitation Science, Osaka Health Sc…. Hauptthemen laut MEDLINE: Valerates, Dietary Supplements, Arginine, Cardiac Surgical Procedures. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND & AIMS: In older patients undergoing cardiac surgery, physical function is a critical determinant of postoperative outcomes. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation has been shown to promote muscle protein anabolism and inhibit catabolism, thereby preventing muscle weakness. However, its efficacy in older patients undergoing cardiac surgery remains unknown. This study aimed to examine the effects of preoperative HMB supplementation on postoperative physical function and complications in this population. METHODS: In this single-center, open-label, randomized controlled trial, patients aged ≥65 years scheduled for cardiac surgery were randomized to receive HMB supplementation or no nutritional intervention. The HMB group received HMB 1200 mg, l-glutamine 7000 mg, and l-arginine 7000 mg, once or twice daily, for at least 2 weeks before surgery. Evaluations were performed at baseline and before and after surgery. The primary outcome was the 6-min walking distance (6MWD) before and after surgery. Secondary outcomes included the incidence of complications, muscle mass and strength, physical performance, and length of hospital stay. RESULTS: Forty-four patients with a mean age of 72.5 years (women, 38 %) were randomized to the HMB (n = 22) or control (n = 22) group. Compared with the control group, the HMB group demonstrated a statistically significant improvement in the 6MWD both at the pre-surgery (448.0 ± 73.5 m vs. 375.5 ± 58.8 m; P = 0.01) and post-surgery time points (428.9 ± 76.4 m vs. 304.5 ± 52.3 m; P = 0.001). Muscle strength and physical performance also showed significant improvements in the HMB group. However, no significant difference in muscle mass was observed between the groups at any time point. The HMB group had a shorter hospital length of stay compared with that of the control group (16.1 ± 3.8 days vs. 20.4 ± 7.6 days, P = 0.03), and no adverse events were observed with the intervention. CONCLUSIONS: Preoperative HMB supplementation in older adults undergoing cardiac surgery resulted in significant improvements in postoperative exercise capacity and physical function, along with a reduction in the length of hospital stay, without affecting muscle mass. REGISTRATION NUMBER OF CLINICAL TRIAL: UMIN000030490 (UMINhttps://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034773).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan; Department of Rehabilitation Science, Osaka Health Science University, Osaka, Japan; Department of Public Health, Kobe Univ…
- Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan. Electronic address: seimik@med.kobe-u.ac.jp.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan; Department of Cardiovascular Aging, National Cerebral and Cardiovascular Center, Osaka, Ja…
- Division of Rehabilitation Medicine, Kobe University Hospital, Hyogo, Japan.
- Department of Nutrition, Kobe University Hospital, Hyogo, Japan.
- Department of Cardiac Surgery, Hyogo Prefectural Awaji Medical Center, Hyogo, Japan.
Zitieren
APA
Ogawa, M., Satomi-Kobayashi, S., Yoshida, N., Komaki, K., Hirabayashi, T., Wakida, K., Saitoh, S., Inoue, T., Yamashita, T., Sakai, Y., Takahashi, M., Okada, K., & Hirata, K. I. (2025). Effects of preoperative beta-hydroxy-beta-methylbutyrate, arginine, and glutamine supplementation on cardiac surgery: A randomized controlled trial. Clinical Nutrition, 45, 91-100. https://doi.org/10.1016/j.clnu.2024.12.030
Vancouver
Ogawa M, Satomi-Kobayashi S, Yoshida N, Komaki K, Hirabayashi T, Wakida K, et al. Effects of preoperative beta-hydroxy-beta-methylbutyrate, arginine, and glutamine supplementation on cardiac surgery: A randomized controlled trial. Clinical Nutrition. 2025;45:91-100. doi:10.1016/j.clnu.2024.12.030
BibTeX
@article{Ogawa2025,
author = {Ogawa, Masato and Satomi-Kobayashi, Seimi and Yoshida, Naofumi and Komaki, Kodai and Hirabayashi, Takumi and Wakida, Kumiko and Saitoh, Saori and Inoue, Takeshi and Yamashita, Tomoya and Sakai, Yoshitada and Takahashi, Michiko and Okada, Kenji and Hirata, Ken-Ichi},
title = {Effects of preoperative beta-hydroxy-beta-methylbutyrate, arginine, and glutamine supplementation on cardiac surgery: A randomized controlled trial},
journal = {Clinical Nutrition},
year = {2025},
volume = {45},
pages = {91--100},
doi = {10.1016/j.clnu.2024.12.030}
}
EUVIMED